Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (DE:3E0)
STUTTGART:3E0
RESEARCH TOOLSreports
Establishment Labs Holdings (3E0) Stock Price & Analysis
1 Followers
3E0 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€23.60 - €63.50
Previous Close€48.6
Volume0.00
Average Volume (3M)100.00
Market Cap
€1.26B
Enterprise Value€1.40B
Total Cash (Recent Filing)$40.03M
Total Debt (Recent Filing)$191.45M
Price to Earnings (P/E)N/A
Beta1.01
Next Earnings
May 08, 2024EPS Estimate
-€0.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume100
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.50
Enterprise Value/Gross Profit13.12
Enterprise Value/Ebitda106.77
Forecast
1Y Price Target
€56.04Price Target Upside18.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Establishment Labs Holdings News
PremiumCompany Announcements
New Regulation Risk for Establishment Labs Holdings – What’s the Latest?
Bulls Say, Bears Say
Bulls Say
Financial GuidanceESTA's initial sales guidance for the year outpaces market expectations, signaling strong revenue growth and confidence from management.
Market ExpansionThe anticipated launch of Motiva in China, coupled with the expanding presence in Asia and Europe, forecasts dynamic growth opportunities for ESTA.
Regulatory ApprovalManagement's expectation of a successful FDA review for Motiva implants hints at a new product launch, potentially boosting the company's market presence.
Bears Say
Financial CovenantsTranche D of the credit facility requires both Tranche C to be drawn and trailing twelve-month sales to exceed $195M.
Market DemandAcknowledging the recent slowdown in demand for breast procedures globally, management said distributor ordering patterns had an outsized impact on Q3 results.
Sales PerformanceAcknowledging the recent slowdown in demand for breast procedures globally, management again said distributor ordering patterns had an outsized impact on Q3 results while direct markets only experienced a single-digit decline.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.87% Other Institutional Investors
97.13% Public Companies and
Individual Investors
3E0 FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was €23.60 and its highest was €63.50 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Currently, no data Available
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is May 08, 2024 which is in 10 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Feb 28, 2024. The company reported -€0.738 earnings per share for the quarter, beating the consensus estimate of -€0.852 by €0.114.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -€0.62.
How many shares outstanding does Establishment Labs Holdings Inc have?
Currently, no data Available
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -€0.738 in its last earnings report, beating expectations of -€0.852. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Among the largest hedge funds holding Establishment Labs Holdings Inc’s share is Iron Triangle Partners LP. It holds Establishment Labs Holdings Inc’s shares valued at 9M.
---
Establishment Labs Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€56.04 (18.72% Upside)
€56.04 (18.72% Upside)
Blogger Sentiment
Bullish
DE:3E0 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.58%
12-Months-Change
Fundamentals
Return on Equity
-1537.75%
Trailing 12-Months
Asset Growth
27.28%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
---
3E0 Earnings Call
Q4 2024
0:00 / 0:00
---
3E0 Stock 12 Months Forecast
Average Price Target
€56.04
▲(18.72% Upside)
Technical Analysis
Establishment Labs Holdings
―
Agile Therapeutics
―
Ascendis Pharma
―
Sensus Healthcare
―
Alimera
―
Best Analysts Covering 3E0
1 Year
1 Year Success Rate
17/38 ratings generated profit
1 Year Average Return
+52.30%
reiterated a buy rating 13 days ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 44.74% of your transactions generating a profit, with an average return of +52.30% per trade.
---